5 Firms Shape Amgen's $13.4B Celgene Drug Buy
Amgen will shell out $13.4 billion in cash to snap up Celgene's psoriasis and psoriatic arthritis drug, a deal shaped by five law firms that is aimed at lessening competition concerns...To view the full article, register now.
Already a subscriber? Click here to view full article